The oxidative species generated in the plasma react to the
pentoxifylline molecule and lead to its oxidative decomposition,
forming several intermediate products, some of
which were successfully identified by LCeMS. The concentrations
of these intermediates showed a fast increase in the
first 30 min of plasma treatment, followed by a slower
decrease. These products were almost completely removed
after 120 min treatment time.